Enfermedades neurodegenerativas: desarrollo de terapias
Buscador de publicaciones
Sólo se han incluido artículos originales, editoriales y revisiones.
-
Devinsky O, Cilio MR, Cross H, Fernandez-Ruiz J, French J, Hill C, Katz R, Di Marzo V, Jutras-Aswad D, Notcutt WG, Martinez-Orgado J, Robson PJ, Rohrback BG, Thiele E, Whalley B, Friedman D.
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
Epilepsia . 55(6): 791-802. Nº de citas: 502
-
Rodríguez-Cueto C, Benito C, Fernández-Ruiz J, Romero J, Hernández-Gálvez M, Gómez-Ruiz M.
Changes in CB1 and CB2 receptors in the post- mortem cerebellum of humans affected by spinocerebellar ataxias
BRITISH JOURNAL OF PHARMACOLOGY . 171(6, SI): 1472-1489. Nº de citas: 39
-
Fernandez-Estevez MA, Casarejos MJ, López Sendon J, Garcia Caldentey J, Ruiz C, Gomez A, Perucho J, de Yebenes JG, Mena MA.
Trehalose Reverses Cell Malfunction in Fibroblasts from Normal and Huntington's Disease Patients Caused by Proteosome Inhibition
Plos One . 9(2): . Nº de citas: 43
-
González-Naranjo P, Pérez-Macias N, Campillo NE, Pérez C, Arán VJ, Girón R, Sánchez-Robles E, Martín MI, Gómez-Cañas M, García-Arencibia M, Fernández-Ruiz J, Páez JA.
Cannabinoid agonists showing BuChE inhibition as potential therapeutic agents for Alzheimer's disease
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY . 73: 56-72. Nº de citas: 36
-
Gonzalo-Gobernado R, Calatrava-Ferreras L, Perucho J, Reimers D, Casarejos MJ, Herranz AS, Jimenez-Escrig A, Diaz-Gil JJ, Bazan E.
Liver growth factor as a tissue regenerating factor in neurodegenerative diseases.
Recent patents on CNS drug discovery . 9(3): 173-180.
-
Rodríguez-Cueto C, Benito C, Romero J, Hernández-Gálvez M, Gómez-Ruiz M, Fernández-Ruiz J.
Endocannabinoid-Hydrolysing Enzymes in the Post-Mortem Cerebellum of Humans Affected by Hereditary Autosomal Dominant Ataxias
Pathobiology . 81(3): 149-159. Nº de citas: 9
-
Fernández-Fernández C, Callado LF, Girón R, Sánchez E, Erdozain AM, López-Moreno JA, Morales P, Rodríguez de Fonseca F, Fernández-Ruiz J, Goya P, Meana JJ, Martín MI, Jagerovic N.
Combining rimonabant and fentanyl in a single entity: preparation and pharmacological results
DRUG DESIGN DEVELOPMENT AND THERAPY . 8: 263-277. Nº de citas: 14
-
Morales P, Vara D, Goméz-Cañas M, Zúñiga MC, Olea-Azar C, Goya P, Fernández-Ruiz J, Díaz-Laviada I, Jagerovic N.
Synthetic cannabinoid quinones: Preparation, in vitro antiproliferative effects and in vivo prostate antitumor activity
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY . 70: 111-119. Nº de citas: 28
-
Espejo-Porras F, Fernández-Ruiz J, Pertwee RG, Mechoulam R, García C.
Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors
Neuropharmacology . 75(SI): 155-163. Nº de citas: 43
-
Pryce G, Cabranes A, Fernández-Ruiz J, Bisogno T, Di Marzo V, Long JZ, Cravatt BF, Giovannoni G, Baker D.
Control of experimental spasticity by targeting the degradation of endocannabinoids using selective fatty acid amide hydrolase inhibitors
MULTIPLE SCLEROSIS JOURNAL . 19(14): 1896-1904. Nº de citas: 27
-
Valhondo M, Marco I, Martín-Fontecha M, Vázquez-Villa H, Ramos JA, Berkels R, Lauterbach T, Benhamú B, López-Rodríguez ML.
New Serotonin 5-HT1A Receptor Agonists Endowed with Antinociceptive Activity in Vivo
JOURNAL OF MEDICINAL CHEMISTRY . 56(20): 7851-7861. Nº de citas: 22
-
Valdeolivas S, Pazos MR, Bisogno T, Piscitelli F, Iannotti FA, Allarà M, Sagredo O, Di Marzo V, Fernández-Ruiz J.
The inhibition of 2-arachidonoyl-glycerol (2-AG) biosynthesis, rather than enhancing striatal damage, protects striatal neurons from malonate-induced death: a potential role of cyclooxygenase-2-dependent metabolism of 2-AG
CELL DEATH & DISEASE . 4: . Nº de citas: 64
-
Perucho J, Casarejos MJ, Gómez A, Ruíz C, Fernández-Estevez MÁ, Muñoz MP, de Yébenes JG, Mena MÁ.
Striatal Infusion of Glial Conditioned Medium Diminishes Huntingtin Pathology in R6/1 Mice
Plos One . 8(9): . Nº de citas: 9
-
Pazos MR, Mohammed N, Lafuente H, Santos M, Martínez-Pinilla E, Moreno E, Valdizan E, Romero J, Pazos A, Franco R, Hillard CJ, Alvarez FJ, Martínez-Orgado J.
Mechanisms of cannabidiol neuroprotection in hypoxic-ischemic newborn pigs: Role of 5HT(1A) and CB2 receptors
Neuropharmacology . 71: 282-291. Nº de citas: 132
-
Gómez del Rio MA, Sánchez-Reus MI, Iglesias I, Pozo MA, García-Arencibia M, Fernández-Ruiz J, García-García L, Delgado M, Benedí J.
Neuroprotective Properties of Standardized Extracts of Hypericum perforatum on Rotenone Model of Parkinson's Disease.
CNS NEUROL DISORD-DR . 12(5): 665-679.
-
Alvarado M, Decara J, Luque MJ, Hernandez-Folgado L, Gómez-Cañas M, Gómez-Ruiz M, Fernández-Ruiz J, Elguero J, Jagerovic N, Serrano A, Goya P, de Fonseca FR.
Novel antiobesity agents: Synthesis and pharmacological evaluation of analogues of Rimonabant and of LH21
BIOORGANIC & MEDICINAL CHEMISTRY . 21(7): 1708-1716. Nº de citas: 16
-
Fernández-Fernández C, Decara J, Bermúdez-Silva FJ, Sánchez E, Morales P, Gómez-Cañas M, Gómez-Ruíz M, Callado LF, Goya P, Rodríguez de Fonseca F, Martín MI, Fernández-Ruíz J, Meana JJ, Jagerovic N.
Description of a Bivalent Cannabinoid Ligand with Hypophagic Properties
ARCHIV DER PHARMAZIE . 346(3): 171-179. Nº de citas: 11
-
Llorente-Folch I, Sahún I, Contreras L, Casarejos MJ, Grau JM, Saheki T, Mena MA, Satrústegui J, Dierssen M, Pardo B.
AGC1-malate aspartate shuttle activity is critical for dopamine handling in the nigrostriatal pathway
JOURNAL OF NEUROCHEMISTRY . 124(3): 347-362. Nº de citas: 12